pamidronate has been researched along with Cerebral Palsy, Athetoid in 11 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of this study was to test the efficacy of low doses of pamidronate in increasing bone mineral density (BMD) in non-ambulatory children and adolescents with cerebral palsy (CP)." | 9.12 | Low doses of pamidronate to treat osteopenia in children with severe cerebral palsy: a pilot study. ( Bruzoni, M; Coughlin, S; Heldt, K; Kreikemeier, R; Lerner, G; Plotkin, H, 2006) |
| "5) nonambulatory children with cerebral palsy or a neuromuscular disorder received cyclic intravenous administration of pamidronate." | 9.11 | Cyclic administration of pamidronate to treat osteoporosis in children with cerebral palsy or a neuromuscular disorder: a clinical study. ( Allington, N; Gerard, P; Vivegnis, D, 2005) |
| "Some children with cerebral palsy (CP) have frequent fractures due to low bone mineral density and receive treatment with pamidronate, an intravenous bisphosphonate." | 7.83 | Pamidronate Treatment to Prevent Reoccurring Fractures in Children With Cerebral Palsy. ( Bachrach, S; Dabney, K; Holmes, L; Kecskemethy, HH; Miller, F; Rogers, KJ; Sees, JP; Sitoula, P, 2016) |
| "The aim of this study was to assess the rate of fracture before and after a 1-year course of intravenous pamidronate in children with spastic quadriplegic cerebral palsy (CP) who had previously experienced fractures." | 7.76 | Decreased fracture incidence after 1 year of pamidronate treatment in children with spastic quadriplegic cerebral palsy. ( Bachrach, SJ; Harcke, HT; Hossain, J; Kecskemethy, HH, 2010) |
| "The aim of this study was to test the efficacy of low doses of pamidronate in increasing bone mineral density (BMD) in non-ambulatory children and adolescents with cerebral palsy (CP)." | 5.12 | Low doses of pamidronate to treat osteopenia in children with severe cerebral palsy: a pilot study. ( Bruzoni, M; Coughlin, S; Heldt, K; Kreikemeier, R; Lerner, G; Plotkin, H, 2006) |
| "5) nonambulatory children with cerebral palsy or a neuromuscular disorder received cyclic intravenous administration of pamidronate." | 5.11 | Cyclic administration of pamidronate to treat osteoporosis in children with cerebral palsy or a neuromuscular disorder: a clinical study. ( Allington, N; Gerard, P; Vivegnis, D, 2005) |
| "To evaluate in a double-blind, placebo-controlled clinical trial the safety and efficacy of intravenous pamidronate to treat osteopenia in nonambulatory children with cerebral palsy." | 5.10 | Bisphosphonates to treat osteopenia in children with quadriplegic cerebral palsy: a randomized, placebo-controlled clinical trial. ( Bachrach, SJ; Harcke, HT; Henderson, RC; Kecskemethy, HH; Lark, RK; Miller, F, 2002) |
| "Some children with cerebral palsy (CP) have frequent fractures due to low bone mineral density and receive treatment with pamidronate, an intravenous bisphosphonate." | 3.83 | Pamidronate Treatment to Prevent Reoccurring Fractures in Children With Cerebral Palsy. ( Bachrach, S; Dabney, K; Holmes, L; Kecskemethy, HH; Miller, F; Rogers, KJ; Sees, JP; Sitoula, P, 2016) |
| "In the nonambulatory cerebral palsy (CP) population with a prior history of fracture, the use of pamidronate is not always effective in preventing further fractures." | 3.78 | Fracture after bisphosphonate treatment in children with cerebral palsy: the role of stress risers. ( Bachrach, SJ; Grissom, LE; Harcke, HT; Kecskemethy, HH; Stevenson, KL, 2012) |
| "Thirty-four children with cerebral palsy and severe osteoporosis were treated for approximately 1 yr with pamidronate (three times per year)." | 3.76 | Risk of corrected QT interval prolongation after pamidronate infusion in children. ( Bougnères, P; Linglart, A; Marchand, I; Rothenbuhler, A, 2010) |
| "The aim of this study was to assess the rate of fracture before and after a 1-year course of intravenous pamidronate in children with spastic quadriplegic cerebral palsy (CP) who had previously experienced fractures." | 3.76 | Decreased fracture incidence after 1 year of pamidronate treatment in children with spastic quadriplegic cerebral palsy. ( Bachrach, SJ; Harcke, HT; Hossain, J; Kecskemethy, HH, 2010) |
| "To determine the effect of intravenous pamidronate on the bone mineral density of children with osteogenesis imperfecta and spastic quadriplegic cerebral palsy." | 3.73 | Bone densitometry in pediatric patients treated with pamidronate. ( Bachrach, SJ; Grissom, LE; Harcke, HT; Kecskemethy, HH; McKay, C, 2005) |
| "In recent years, bisphosphonates, primarily intravenous (iv) pamidronate, have become very widely used in children with severe osteogenesis imperfecta (OI)." | 3.73 | Low doses of pamidronate for the treatment of osteopenia in non-ambulatory children. ( Henderson, R, 2006) |
| "Pain is one of the most common symptoms in children and young people (CYP) with life-limiting conditions (LLCs) which include a wide range of diagnoses including cancer." | 2.52 | Pharmacological interventions for pain in children and adolescents with life-limiting conditions. ( Beecham, E; Bluebond-Langner, M; Candy, B; Howard, R; Jones, L; Laddie, J; McCulloch, R; Rees, H; Vickerstaff, V, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (54.55) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sees, JP | 1 |
| Sitoula, P | 1 |
| Dabney, K | 1 |
| Holmes, L | 1 |
| Rogers, KJ | 1 |
| Kecskemethy, HH | 5 |
| Bachrach, S | 1 |
| Miller, F | 2 |
| Beecham, E | 1 |
| Candy, B | 1 |
| Howard, R | 1 |
| McCulloch, R | 1 |
| Laddie, J | 1 |
| Rees, H | 1 |
| Vickerstaff, V | 1 |
| Bluebond-Langner, M | 1 |
| Jones, L | 1 |
| Rothenbuhler, A | 1 |
| Marchand, I | 1 |
| Bougnères, P | 1 |
| Linglart, A | 1 |
| Bachrach, SJ | 4 |
| Harcke, HT | 5 |
| Hossain, J | 1 |
| Stevenson, KL | 1 |
| Grissom, LE | 3 |
| Henderson, RC | 1 |
| Lark, RK | 1 |
| McKay, C | 1 |
| Allington, N | 1 |
| Vivegnis, D | 1 |
| Gerard, P | 1 |
| Henderson, R | 1 |
| Plotkin, H | 1 |
| Coughlin, S | 1 |
| Kreikemeier, R | 1 |
| Heldt, K | 1 |
| Bruzoni, M | 1 |
| Lerner, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Prevention of Bone Loss After Pediatric Hematopoietic Cell Transplantation[NCT02074631] | Phase 2 | 80 participants (Actual) | Interventional | 2015-02-28 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for pamidronate and Cerebral Palsy, Athetoid
| Article | Year |
|---|---|
Pharmacological interventions for pain in children and adolescents with life-limiting conditions.
Topics: Adolescent; Alendronate; Baclofen; Botulinum Toxins, Type A; Cerebral Palsy; Child; Child, Preschool | 2015 |
3 trials available for pamidronate and Cerebral Palsy, Athetoid
| Article | Year |
|---|---|
Bisphosphonates to treat osteopenia in children with quadriplegic cerebral palsy: a randomized, placebo-controlled clinical trial.
Topics: Adolescent; Bone Diseases, Metabolic; Cerebral Palsy; Child; Diphosphonates; Double-Blind Method; Fe | 2002 |
Cyclic administration of pamidronate to treat osteoporosis in children with cerebral palsy or a neuromuscular disorder: a clinical study.
Topics: Adolescent; Anti-Inflammatory Agents; Cerebral Palsy; Child; Child, Preschool; Diphosphonates; Drug | 2005 |
Low doses of pamidronate to treat osteopenia in children with severe cerebral palsy: a pilot study.
Topics: Adolescent; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Cerebral Palsy | 2006 |
7 other studies available for pamidronate and Cerebral Palsy, Athetoid
| Article | Year |
|---|---|
Pamidronate Treatment to Prevent Reoccurring Fractures in Children With Cerebral Palsy.
Topics: Adolescent; Bone Density Conservation Agents; Cerebral Palsy; Child; Child, Preschool; Diphosphonate | 2016 |
Risk of corrected QT interval prolongation after pamidronate infusion in children.
Topics: Adolescent; Arrhythmias, Cardiac; Cerebral Palsy; Child; Diphosphonates; Electrocardiography; Female | 2010 |
Decreased fracture incidence after 1 year of pamidronate treatment in children with spastic quadriplegic cerebral palsy.
Topics: Adolescent; Age Factors; Bone Density; Bone Density Conservation Agents; Cerebral Palsy; Child; Chil | 2010 |
Fracture after bisphosphonate treatment in children with cerebral palsy: the role of stress risers.
Topics: Adolescent; Bone Density Conservation Agents; Cerebral Palsy; Child; Child, Preschool; Diphosphonate | 2012 |
Radiographic features of bisphosphonate therapy in pediatric patients.
Topics: Adolescent; Bone and Bones; Bone Density; Bone Development; Bone Diseases, Metabolic; Cerebral Palsy | 2003 |
Bone densitometry in pediatric patients treated with pamidronate.
Topics: Absorptiometry, Photon; Adolescent; Adult; Bone Density; Cerebral Palsy; Child; Child, Preschool; Di | 2005 |
Low doses of pamidronate for the treatment of osteopenia in non-ambulatory children.
Topics: Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Cerebral Palsy; Child; Chi | 2006 |